#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Prader-Willi syndrome Neuromyelitis optica spectrum disorder Thromboangiitis obliterans Paraganglion neoplasm Uterine leiomyosarcoma Non-small cell lung cancer recurrent ROHHAD syndrome Philadelphia positive chronic myeloid leukaemia Pulmonary hypertension Small for dates baby Heavy menstrual bleeding Malignant neoplasm of choroid Breast angiosarcoma Mucopolysaccharidosis II Chronic granulomatous disease More trials…

    Learn about Rare Diseases

    Urea cycle disorder – Diagnostics Congenital hypotransferrinaemia Activated PI3 kinase delta syndrome – Basic Information Myelodysplastic syndrome with excess blasts – Diagnostics Progressive supranuclear palsy Hereditary neuropathic amyloidosis – Diagnostics Haemophilia B with anti factor IX – Treatment Angiosarcoma – Diagnostics Breast angiosarcoma metastatic – Diagnostics Hyperoxaluria – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    TRV045 Rhh646 Alitretinoin Guselkumab Ubiquinol Clonidine Hydrochloride Surzebiclimab Imifoplatin Pamapimod Desvenlafaxine Benzoate LY3537031 Azd8205 Adct-402 Nilotinib Radium Ra 223 Dichloride Mosliciguat Clazakizumab Clodronate Disodium Anthoxanthum Odoratum Rigosertib Sodium More therapies…

    Learn about Your Condition

    Haemorrhoids Thyroid mass Hyperphagia Polyneuropathy Colorectal cancer stage III Thrombocytosis Osteochondrodysplasia Peripheral artery thrombosis Limb reduction defect Leber's congenital amaurosis Lipid metabolism disorder Colitis ulcerative Myofascial pain syndrome Muscle strain Psychological trauma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Diagnosis

  • Standardization of Olea europaea pollen extract for patients with olive pollen allergies

    Recruiting

    2 1 1
    Investigated Diseases:
    • Hypersensitivity
    Investigated Drugs:
    • Histamine Dihydrochloride
    • Olea Europaea Pollen Extract
    • Sodium Chloride
    Spain

  • A study comparing the effectiveness of a simeticone drug combination and a sodium picosulfate drug combination for bowel preparation in patients undergoing colorectal cancer screening.

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Colorectal cancer
    Investigated Drugs:
    • Citric Acid
    • Magnesium Oxide, Light
    • Sodium Citrate
    Spain

  • A study to evaluate the use of FAPI-46 (68Ga) imaging to detect peritoneal cancer spread in patients with colorectal, gastric, ovarian, or pancreatic cancer

    Recruiting

    4 1 1
    Investigated Diseases:
    • Gastric cancer
    • Pancreatic carcinoma
    • Colorectal cancer
    Investigated Drugs:
    • (S)-2,2′,2”-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate
    The Netherlands Sweden

  • Early detection of heart damage using cardiac magnetic resonance imaging in cancer patients receiving doxorubicin, epirubicin, pixantrone and other anthracyclines

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Chemotherapy cardiotoxicity attenuation
    Investigated Drugs:
    • Mitoxantrone Hydrochloride
    • Epirubicin Hydrochloride
    • Idarubicin Hydrochloride
    Germany

  • Study to Evaluate IOpener-Melanoma Test for Predicting Response to Immunotherapy in Stage III or IV Skin Melanoma Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Malignant melanoma
    Investigated Drugs:
    • Nivolumab
    • Pembrolizumab
    The Netherlands

  • Study Comparing Intravenous Contrast CT with Non-Contrast CT for Patients with Acute Abdominal Pain and Reduced Kidney Function Using Iohexol

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Renal impairment
    Investigated Drugs:
    • Iohexol
    Finland Norway
1 2 3 … 22
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!